74 pending office actions • 53 clients
| App # | Title | Client | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|---|
| 19397424 | Untitled | DANA-FARBER CANCER INSTITUTE, INC. | KENNEDY, SARAH JANE | 1682 | Non-Final OA | |
| 19252263 | Untitled | Light Tackle Anglers, LLC | JORDAN, MORGAN T | 3643 | Non-Final OA | |
| 18931358 | OUTDOOR TABLETOP SYSTEM | Agio International Company, Limited | ING, MATTHEW W | 3637 | Non-Final OA | Oct 30, 2024 |
| 18907240 | METHOD FOR EFFICIENT DRUG ADMINISTRATION ACROSS THE BLOOD-BRAIN BARRIER AND USES THEREOF | Carthera | MATTSON, SEAN D | 3798 | Non-Final OA | Oct 04, 2024 |
| 18853074 | ENDOSCOPE DEVICE WITH A SUPPORT MECHANISM | Unknown | NEAL, TIMOTHY JAY | 3795 | Non-Final OA | Sep 30, 2024 |
| 18844840 | OPTICAL SENSOR, OPTICAL ARRANGEMENT AND METHOD FOR DETERMINING A REAL-TIME FLUID PROPERTY OF PARTICLES IN A TURBID MEDIUM | Agency for Science, Technology and Research | COOK, JONATHON | 2877 | Non-Final OA | Sep 06, 2024 |
| 18817610 | SELF-CENTERING ENERGY DISSIPATION DEVICE AND WALL DAMPING ASSEMBLY | National Applied Research Laboratories | CAJILIG, CHRISTINE T | 3633 | Non-Final OA | Aug 28, 2024 |
| 18734819 | SEAM TAPES AND METHODS OF MAKING THE SAME | Bemis Associates, Inc. | FISCHER, JUSTIN R | 1749 | Non-Final OA | Jun 05, 2024 |
| 18655035 | SYSTEM WITH AUTOMATED DISPLAY FOR BEVERAGE AND/OR FLOWABLE EDIBLE PRODUCT DISPENSING | Unknown | NICOLAS, FREDERICK C | 3754 | Non-Final OA | May 03, 2024 |
| 18611819 | METHOD FOR MANUFACTURING VANILLA PRODUCT | Unknown | MCNEIL, JENNIFER C | 1793 | Non-Final OA | Mar 21, 2024 |
| 18598314 | CONNECTOR ASSEMBLY AND LANYARD LOOP HAVING THE SAME | Castip Industrial Co., Ltd. | DO, ROWLAND | 3677 | Non-Final OA | Mar 07, 2024 |
| 18428912 | INHIBITORS OF EPIDERMAL GROWTH FACTOR RECEPTOR | National Health Research Institutes | SHIAO, REI TSANG | 1691 | Non-Final OA | Jan 31, 2024 |
| 18545168 | REUSABLE FOOD OR BEVERAGE CONTAINER SANITIZING AND WASHING SYSTEM | Redi Technology, Inc. | PARIHAR, PRADHUMAN | 1714 | Non-Final OA | Dec 19, 2023 |
| 18571123 | NOVEL COMPOUNDS FOR THE TREATMENT AND PREVENTION OF NEUROLOGICAL COMPLICATIONS OF VIRAL INFECTIONS | Sunregen Healthcare AG | MI, QIUWEN | 1655 | Non-Final OA | Dec 15, 2023 |
| 18533542 | THIN-SHELL POLYMERIC NANOPARTICLES AND USES THEREOF | Academia Sinica | PHAN, DOAN THI-THUC | 1613 | Final Rejection | Dec 08, 2023 |
| 18525721 | COMPOUNDS FOR IMPROVED VIRAL TRANSDUCTION | Genetix Biotherapeutics Inc. | MONTANARI, DAVID A | 1632 | Non-Final OA | Nov 30, 2023 |
| 18517497 | BRIARANE COMPOUNDS AND THEIR USE | National Museum Of Marine Biology And Aquarium | SHI, GENBIN | 1628 | Non-Final OA | Nov 22, 2023 |
| 18561712 | TREATMENT OF ANTIPHOSPHOLIPID SYNDROME USING S-HYDROXYCHLOROQUINE | Genovate Biotechnology Co. Ltd. | VAJDA, KRISTIN ANN | 1622 | Non-Final OA | Nov 16, 2023 |
| 18560883 | ENGINEERED CELLS, ENZYMES, AND METHODS FOR PRODUCING CANNABINOIDS | Cellibre, Inc. | SELWANES, JOHN PAUL | 1651 | Non-Final OA | Nov 14, 2023 |
| 18508761 | NUCLEIC ACID CONSTRUCTS ENCODING REPROGRAMMING FACTORS LINKED BY SELF-CLEAVING PEPTIDES | Whitehead Institute Of Biomedical Research | BERTOGLIO, VALARIE E | 1632 | Non-Final OA | Nov 14, 2023 |
| 18289538 | QUANTUM ILLUMINATION USING AN ION TRAP | The University of Sussex | STOFFA, WYATT A | 2881 | Final Rejection | Nov 03, 2023 |
| 18289213 | ELAFIBRANOR DERIVATIVES AGONISTS OF PPAR FOR USE IN THE TREATMENT OF SEPSIS | Genfit | BARHAM, BETHANY P | 1611 | Non-Final OA | Nov 01, 2023 |
| 18289211 | PPAR-AGONISTS FOR USE IN THE TREATMENT OF LIVER FAILURE | Genfit | HABTE, KAHSAY | 1624 | Non-Final OA | Nov 01, 2023 |
| 18495731 | METHODS AND COMPOSITIONS FOR IN VIVO DIRECT GENOME EDITING IN PLANTS | The Regents of the University of California | KUMAR, VINOD | 1663 | Non-Final OA | Oct 26, 2023 |
| 18287847 | FLOATING STRUCTURE | Seatrium (Sg) Pte. Ltd. | POLAY, ANDREW | 3615 | Non-Final OA | Oct 20, 2023 |
| 18382048 | SERUM-FREE IN VITRO DIRECTED DIFFERENTIATION PROTOCOL FOR GENERATING STEM CELL-DERIVED BETA CELLS AND USES THEREOF | President and Fellows of Harvard College | MONTANARI, DAVID A | 1632 | Non-Final OA | Oct 19, 2023 |
| 18285494 | CHEMICAL REPROGRAMMING OF HUMAN SOMATIC CELLS INTO PLURIPOTENT CELLS | Peking University | MIANO, JOSEPH PAUL | 1631 | Non-Final OA | Oct 03, 2023 |
| 18374326 | INHIBITORS OF POSITIVE STRAND RNA VIRUSES | National Health Research Institutes | VALLE, ERNESTO | 1623 | Non-Final OA | Sep 28, 2023 |
| 18231190 | METHODS FOR GENERATING NEURAL TISSUE AND USES THEREOF | President and Fellows of Harvard College | MOLOYE, TITILAYO | 1632 | Non-Final OA | Aug 07, 2023 |
| 18227540 | GDF11 VARIANTS AND USES THEREOF | President and Fellows of Harvard College | LEE, JIA-HAI | 1658 | Non-Final OA | Jul 28, 2023 |
| 18353440 | CELL-NANOPARTICLE DRUG DELIVERY SYSTEM AND USE OF THE SAME FOR INHIBITING GROWTH OF TUMOR CELLS AND DIAGNOSING TUMOR CELLS | National Yang Ming Chiao Tung University | SMITH, ADAM MICHAEL | 1638 | Non-Final OA | Jul 17, 2023 |
| 18352719 | METHOD FOR INDUCING SALMONELLA ENTERITIDIS INTO VBNC STATE BY SODIUM HYPOCHLORITE | China Jiliang University | JONES-FOSTER, ERICA NICOLE | 1656 | Non-Final OA | Jul 14, 2023 |
| 18338089 | CYTARABINE-MODIFIED miRNA FOR TREATING CANCER | Curamir Therapeutics, Inc. | MEYERING, SHABANA SHABBEER | 1635 | Non-Final OA | Jun 20, 2023 |
| 18268240 | METHODS OF CANCER DETECTION USING EXTRAEMBRYONICALLY METHYLATED CPG ISLANDS | DANA-FARBER CANCER INSTITUTE, INC. | KENNEDY, SARAH JANE | 1682 | Non-Final OA | Jun 18, 2023 |
| 18035697 | NOVEL CAPSAICIN ANALOGS AND USES THEREOF | Young Biopharma, LLC | FETTEROLF, BRANDON J | 1626 | Non-Final OA | May 05, 2023 |
| 18035358 | SYSTEMS FOR BUCCAL RELEASE OF PROTEINS | UNIVERSITE CLAUDE BERNARD - LYON 1 | BROWE, DAVID | 1617 | Non-Final OA | May 04, 2023 |
| 18034876 | USE OF BRAIN ORGANOIDS AND SINGLE CELL GENOMICS TO UNDERSTAND AND TREAT NEURODEVELOPMENTAL AND NEUROPSYCHIATRIC DISORDERS | Massachusetts Institute Of Technology | KAPUSHOC, STEPHEN THOMAS | 1683 | Non-Final OA | May 01, 2023 |
| 18034669 | DUAL TARGETING CHIMERIC ANTIGEN RECEPTORS | The University of North Carolina at Chapel Hill | SWARTWOUT, BRIANNA KENDALL | 1644 | Non-Final OA | Apr 28, 2023 |
| 18034251 | APPARATUS AND METHOD FOR PROMPTING CONSCIOUS BREATHING | Zeeno Pty Ltd. | BOECKER, JOSEPH D | 3785 | Non-Final OA | Apr 27, 2023 |
| 18135773 | PATCH SYSTEM FOR MONITORING AND ENHANCING SLEEP AND CIRCADIAN RHYTHM ALIGNMENT | Circadian Positioning Systems, Inc. | DORNA, CARRIE R | 3791 | Non-Final OA | Apr 18, 2023 |
| 18119399 | REUSABLE FOOD OR BEVERAGE CONTAINER SANITIZING SYSTEM | Redi Technology, Inc. | SARANTAKOS, KAYLA ROSE | 1799 | Non-Final OA | Mar 09, 2023 |
| 18023086 | METHODS OF PREPARING IRON COMPLEXES | LG Bionano, LLC | LIU, SUE XU | 1616 | Non-Final OA | Feb 24, 2023 |
| 18021156 | EX VIVO BRAIN TUMOR MODEL | Massachusetts Institute Of Technology | REGLAS, GILLIAN CHELSEA | 1632 | Non-Final OA | Feb 13, 2023 |
| 18019188 | GRIP FOR RACKET | Gripfixer Holding Aps | LEGESSE, NINI F | 3711 | Non-Final OA | Feb 01, 2023 |
| 18015521 | AAV VECTOR DELIVERY SYSTEMS | President and Fellows of Harvard College | GOMEZ RODRIGUEZ, JULIO WASHINGTON | 1637 | Non-Final OA | Jan 10, 2023 |
| 18009731 | A CELLULAR MARKER OF COVID SEVERITY | Sorbonne Universite | QIAN, CELINE X | 1637 | Non-Final OA | Dec 11, 2022 |
| 17925801 | COMPOSITIONS AND METHODS FOR INCREASING LACTATION | Unknown | LACHICA, ERICSON M | 1792 | Final Rejection | Nov 16, 2022 |
| 17945709 | METHOD OF BIOMARKER DETECTION IN COMPANION ANIMALS | Uni Pharma Co., LTD. | HUANG, MICKEY NMN | 1758 | Non-Final OA | Sep 15, 2022 |
| 17940385 | METHOD FOR PROCESSING VANILLA POD | Unknown | MORENO, LARK JULIA | 1793 | Non-Final OA | Sep 08, 2022 |
| 17894333 | METHODS OF TREATING CDGSH IRON SULFUR DOMAIN 2 INSUFFICIENCY-ASSOCIATED DISORDERS | Chang Gung Medical Foundation, Chang Gung Memorial Hospital, Linkou | COPPINS, JANET L | 1628 | Non-Final OA | Aug 24, 2022 |
| 17799162 | CHLOROSULFONATED POLYPROPYLENE CARBONATE, AND PRODUCTION METHOD AND USE THEREOF | Changchun Institute Of Applied Chemistry Chinese Academy Of Sciences | DU, SURBHI M | 1765 | Final Rejection | Aug 11, 2022 |
| 17786517 | METHODS AND COMPOSITIONS FOR CORRECTION OF DMD MUTATIONS | President and Fellows of Harvard College | FOX, ALLISON M | 1633 | Final Rejection | Jun 16, 2022 |
| 17783573 | ALDH3A2 INHIBITION AND FERROPTOSIS INDUCTION FOR CANCER THERAPY | Shrikanta Chattopadhyay | HUDSON, AMY ROSE | 1636 | Final Rejection | Jun 08, 2022 |
| 17782908 | INFLAMMATION-RESPONSIVE ANTI-INFLAMMATORY HYDROGELS | Nanyang Technological University | JONES, DAMERON LEVEST | 1618 | Non-Final OA | Jun 06, 2022 |
| 17829917 | METHODS OF INCREASING CELL PHAGOCYTOSIS | Academia Sinica | KUCHARCZK, JED A | 1623 | Final Rejection | Jun 01, 2022 |
| 17778382 | ANTI-PD-L1/ANTI-B7-H3 MULTISPECIFIC ANTIBODIES AND USES THEREOF | I-Mab | NICKOL, GARY B | 1643 | Non-Final OA | May 19, 2022 |
| 17772913 | NOVEL PROLYLFK506 DERIVATIVES HAVING NEURITE GROWTH AND SYNAPSE FORMATION ACTIVITIES AND USES THEREOF | Molgenbio Co. Ltd. | RICCI, CRAIG D | 1611 | Final Rejection | Apr 28, 2022 |
| 17728927 | THERAPEUTIC USES OF GENOME EDITING WITH CRISPR/Cas SYSTEMS | The Children's Hospital of Philadelphia | WILSON, MICHAEL C | 1638 | Non-Final OA | Apr 25, 2022 |
| 17770281 | COMPOSITIONS AND METHODS FOR ENHANCING DIFFERENTIATION OF STEM CELL-DERIVED BETA CELLS | President and Fellows of Harvard College | BARRON, SEAN C | 1653 | Final Rejection | Apr 19, 2022 |
| 17763441 | NANOPARTICLE COMPOSITIONS FOR GENE THERAPY | UNIVERSITY COLLEGE DUBLIN | LIPPOLIS, ALEXANDRA ROSE | 1637 | Non-Final OA | Mar 24, 2022 |
| 17762360 | MODIFIED T CELLS AND METHODS OF PREPARING THE SAME | The University of North Carolina at Chapel Hill | BOESEN, AGNIESZKA | 1672 | Final Rejection | Mar 21, 2022 |
| 17641059 | TRANSDUCTION EFFICIENCY ASSAY | Genetix Biotherapeutics Inc. | JADHAO, SAMADHAN JAISING | 1672 | Final Rejection | Mar 07, 2022 |
| 17540968 | MODIFIED T CELLS AND METHODS OF MAKING AND USING THE SAME | President and Fellows of Harvard College | WEHBE, ANNE MARIE SABRINA | 1634 | Final Rejection | Dec 02, 2021 |
| 17615579 | REPRODUCIBLE BRAIN ORGANOIDS AND METHODS OF MAKING | The Broad Institute, Inc. | BEHARRY, ZANNA MARIA | 1632 | Non-Final OA | Nov 30, 2021 |
| 17611560 | METHODS OF CHARACTERIZING AND UTILIZING AGENT-CONDENSATE INTERACTIONS | Whitehead Institute For Biomedical Research | PERREIRA, MELISSA JEAN | 1618 | Non-Final OA | Nov 15, 2021 |
| 17608463 | PEPTIDE DERIVATIVES AND CONJUGATES THEREOF FOR TREATING CANCER | The University of Sydney | REYNOLDS, FRED H | 1658 | Final Rejection | Nov 02, 2021 |
| 17598963 | METHODS TO ENHANCE T CELL REGENERATION | President and Fellows of Harvard College | BEHARRY, ZANNA MARIA | 1632 | Final Rejection | Sep 28, 2021 |
| 17383941 | METHODS AND DEVICES FOR REPAIR OF CRUSHED PERIPHERAL NERVE INJURIES WITH ERYTHROPOIETIN | Shu-Tung And Alice Li Foundation Inc. | BASQUILL, SEAN M | 1614 | Final Rejection | Jul 23, 2021 |
| 17418305 | METHOD FOR STABILIZING BIOACTIVITY OF GROWTH FACTOR | National Cheng Kung University | NIEBAUER, RONALD T | 1658 | Final Rejection | Jun 25, 2021 |
| 17182044 | GENE EXPRESSION-BASED BIOMARKER FOR THE DETECTION AND MONITORING OF BRONCHIAL PREMALIGNANT LESIONS | Trustees Of Boston University | GROSS, CHRISTOPHER M | 1684 | Final Rejection | Feb 22, 2021 |
| 17040967 | METHODS AND ASSAYS FOR MODULATING GENE TRANSCRIPTION BY MODULATING CONDENSATES | Massachusetts Institute Of Technology | PERREIRA, MELISSA JEAN | 1618 | Non-Final OA | Sep 23, 2020 |
| 16924158 | RNA WITH A COMBINATION OF UNMODIFIED AND MODIFIED NUCLEOTIDES FOR PROTEIN EXPRESSION | Ethris GmbH | NGUYEN, QUANG | 1631 | Final Rejection | Jul 08, 2020 |
| 15818710 | GUIDE RIBONUCLEIC ACID SEQUENCES THAT TARGET THE CCR5 GENE | The Children's Hospital of Philadelphia | WILSON, MICHAEL C | 1638 | Final Rejection | Nov 20, 2017 |
| 15282905 | COMPOSITIONS AND METHODS FOR ALTERING GENE EXPRESSION | Whitehead Institute For Biomedical Research | NGUYEN, QUANG | 1631 | Final Rejection | Sep 30, 2016 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial